Characteristics of early-onset neonatal sepsis caused by Escherichia coli

Taiwanese Journal of Obstetrics and Gynecology

Volumn 51, Issue 1, 2012, Pages 26-30

  Tsai, Chin Han ^a   Chen, Yi Yung ^a   Wang, Kuo Gon ^a   Chen, Chen Yu ^a   Chen, Chie Pein ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Antibiotic resistance; Early onset neonatal sepsis; Escherichia coli; Prematurity

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; GENTAMICIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; FETUS DISEASE; FEVER; GESTATIONAL AGE; HUMAN; INFANT; INFECTION RISK; INTRAPARTUM FEVER; MALE; NEWBORN; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PROLONGED FETUS MEMBRANE RUPTURE; RETROSPECTIVE STUDY; VERY LOW BIRTH WEIGHT;

ADULT; ANTI-BACTERIAL AGENTS; BIRTH WEIGHT; CASE-CONTROL STUDIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; FEVER; GESTATIONAL AGE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT, NEWBORN; MALE; PENICILLIN RESISTANCE; PREGNANCY; PREMATURE BIRTH; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

EID: 84862822578     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2012.01.006     Document Type: Article

References (28)

1. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002, 347:240-247.
2. Stoll B.J., Hansen N.I., Higgins R.D., Fanaroff A.A., Duara S., Goldberg R., et al. Very low birth weight preterm infants with early onset neonatal sepsis. Pediatr Infect Dis J 2005, 24:635-639.
3. Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996, 45:1-24.
4. Schrag S., Gorwitz R., Fultz-Butts K., Schuchat A. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR Recomm Rep 2002, 51:1-22.
5. Moore M.R., Schrag S.J., Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003, 3:201-213.
6. Bizzarro M.J., Dembry L.M., Baltimore R.S., Gallagher P.G. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008, 121:689-696.
7. Hyde T.B., Hilger T.M., Reingold A., Farley M.M., O'Brien K.L., Schuchat A. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002, 110:690-695.
8. Alarcon A., Peña P., Salas S., Sancha M., Omeñaca F. Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis. Pediatr Infect Dis J 2004, 23:295-299.
9. Schrag S.J., Hadler J.L., Arnold K.E., Martell-Cleary P., Reingold A., Schuchat A. Risk factors for invasive, early-onset Escherichia coli infection in the era of widespread intrapartum antibiotic use. Pediatrics 2006, 118:570-576.
10. Yancey M.K., Duff P., Kubilis P., Clark P., Frentzen B.H. Risk factors for neonatal sepsis. Obstet Gynecol 1996, 87:188-194.
11. Schuchat A., Zywicki S.S., Dinsmoor M.J., Mercer B., Romaguera J., O'Sullivan M.J. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case control study. Pediatrics 2000, 105:21-26.
12. Bevilacqua G., Braibanti S., Solari E., Anfuso S., Fragni G., Soncini E. Perinatal risk factors for infection in the newborn. Multicenter clinico-epidemiologic investigation. Pediatr Med Chir 2005, 27:31-38.
13. Towers C.V., Briggs G.G. Antepartum use of antibiotics and early-onset neonatal sepsis: the next 4 years. Am J Obstet Gynecol 2002, 187:495-500.
14. Mercer B.M., Carr T.L., Beazley D.D., Crouse D.T., Sibai B.M. Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol 1999, 181:816-821.
15. Edwards R.K., Clark P., Sistrom C.L., Duff P. Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on gram-negative pathogens. Obstet Gynecol 2002, 100:534-539.
16. Schuchat A. Impact of intrapartum chemoprophylaxis on neonatal sepsis. Pediatr Infect Dis J 2003, 22:1087-1088.
17. Schrag S.J., Stoll B.J. Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis. Pediatr Infect Dis J 2006, 25:939-940.
18. Mehr S.S., Sadowsky J.L., Doyle L.W., Carr J. Sepsis in neonatal intensive care in the late 1990s. J Paediatr Child Health 2002, 38:246-251.
19. Jones B., Peake K., Morris A.J., McCowan L.M., Battin M.R. Escherichia coli: a growing problem in early onset neonatal sepsis. Aust N Z J Obstet Gynaecol 2004, 44:558-561.
20. Newman D.E., Paamoni-Keren O., Press F., Wiznitzer A., Mazor M., Sheiner E. Neonatal outcome in preterm deliveries between 23 and 27 weeks' gestation with and without preterm premature rupture of membranes. Arch Gynecol Obstet 2009, 280:7-11.
21. Gomez R., Romero R., Nien J.K., Medina L., Carstens M., Kim Y.M., et al. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med 2007, 20:167-173.
22. Ovalle A., Martínez M.A., Kakarieka E., Gómez R., Rubio R., Valderrama O., et al. Antibiotic administration in patients with preterm premature rupture of membranes reduces the rate of histological chorioamnionitis: a prospective, randomized, controlled study. J Matern Fetal Neonatal Med 2002, 12:35-41.
23. Kenyon S., Boulvain M., Neilson J. Antibiotics for preterm rupture of the membranes: a systematic review. Obstet Gynecol 2004, 104:1051-1057.
24. Schrag S., Schuchat A. Prevention of neonatal sepsis. Clin Perinatol 2005, 32:601-615.
25. Rentz A.C., Samore M.H., Stoddard G.J., Faix R.G., Byington C.L. Risk factors associated with ampicillin-resistant infection in newborns in the era of group B streptococcal prophylaxis. Arch Pediatr Adolesc Med 2004, 158:556-560.
26. Joseph T.A., Pyati S.P., Jacobs N. Neonatal early-onset Escherichia coli disease: the effect of intrapartum ampicillin. Arch Pediatr Adolesc Med 1998, 152:35-40.
27. Friedman S., Shah V., Ohlsson A., Matlow A.G. Neonatal Escherichia coli infections: concerns regarding resistance to current therapy. Acta Paediatr 2000, 89:686-689.
28. Vergnano S., Menson E., Kennea N., Embleton N., Russell A.B., Watts T., et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011, 96:F9-14.